Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Nutraperf Consumption in Runners

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00799630
Recruitment Status : Completed
First Posted : December 1, 2008
Last Update Posted : December 1, 2008
Sponsor:
Collaborators:
Centre Hospitalier Universitaire de Saint Etienne
Université Savoie Mont Blanc
Information provided by:
Lescuyer Laboratory

Brief Summary:

Exercise has numerous health benefits. Nevertheless, when exercise duration is ~45 min or longer and intensity moderate to intense, it may induce different troubles, for example: hypoglycemia, peripheral and central fatigue, muscle damages, osteoarticular injuries, inflammation, cardiovascular dysfunctions. Nutritional loading during exercise may prevent and and/or reduce some of these troubles.

In regard of recent data, we proposed a novel energy drink (NUTRAPERF®) to limit deleterious effects of long time exercise in neutral environment (outside temperature between 4 and 25°C) and to improve performance. If performance may be increased by this energy drink during long time exercise, we proposed that it consumption may also improve performance in short and sub-maximal exercise.

So, the purpose of this study is to investigate the effects of the consumption of this novel energy drink on performance during long and short time exercise. Moreover, we studied the effects of this consumption on different metabolic parameters (heart rate, oxygen consumption, respiratory quotient, ventilation, glycemia, lactatemia), on central and peripheral fatigue and on cognitive parameters.


Condition or disease Intervention/treatment Phase
Nutrition Processes Dietary Supplement: Carbohydrate drink Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Official Title: Identification of the Effects of NUTRAPERF Consumption on Performance in Endurance-Type Exercise.
Study Start Date : November 2008

Intervention Details:
  • Dietary Supplement: Carbohydrate drink
    Maltodextrins, dextrose, fructose, amino acids (leucine, isoleucine, valine), natural flavors, sodium chloride, magnesium citrate, zinc, lactate, acid: malic acid, anti-caking agent: silicon dioxide; Curcumin (turmeric extract) , Thickener: xanthan gum, caffeine, vitamin C (Acerola extract), vitamin E - B1 - B2 - B3; piperine (black pepper extract).
    Other Name: NUTRAPERF



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria

  • Man aged between 18 and 45 years.
  • Regular sportsman (2 to 4 workouts by week since 3 months minimum).
  • Be a long-distance runner.
  • Be affiliated or beneficial to the National French Security Social.

Non-inclusion criteria

  • Any subject who was injured during the three preceding months study.
  • Any subject with a history of disease can disrupt the tests. In particular, subjects with pathological conditions placed on the joints of the knee or ankle (sprain repeated problems or patellar ligament) that could hamper measures of force maximum extension and flexion on these joints or illnesses that prevent the exercise of pedalling or running on treadmill (tendonitis, periostitis) will be excluded.
  • Any subject who at the same time participates at another medical experiment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00799630


Locations
Layout table for location information
France
Service de Physiologie Clinique et de l'Exercice, CHU Saint-Etienne
Saint-Etienne, France, 42055
Sponsors and Collaborators
Lescuyer Laboratory
Centre Hospitalier Universitaire de Saint Etienne
Université Savoie Mont Blanc

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Lescuyer laboratory, industry
ClinicalTrials.gov Identifier: NCT00799630     History of Changes
Other Study ID Numbers: 2008-A00982-53
First Posted: December 1, 2008    Key Record Dates
Last Update Posted: December 1, 2008
Last Verified: November 2008

Keywords provided by Lescuyer Laboratory:
energy drink
exercise
BCAA
peripheral and central fatigue